Noah Medical Continues Momentum, Named Both “Best Healthcare Robotics Company” and a “Bay Area Best Places to Work”
May 10, 2023 11:18 ET
|
Noah Medical
SAN CARLOS, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today announced it was named the “2023 Best Healthcare Robotics Company” in the 7th Annual MedTech...
Breakthrough Leads a Movement to Fix a US Healthcare System in Crisis
November 10, 2022 10:46 ET
|
Breakthrough
DENVER, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Within 72 hours, more than one hundred physical therapists signed Breakthrough's pledge to fix the healthcare system last week at the American Physical...
NDB Was Granted An Award From The Government
July 13, 2022 11:00 ET
|
NDB Inc.
SAN FRANCISCO, July 13, 2022 (GLOBE NEWSWIRE) -- NDB, Inc. - The quest for innovations touched every human area, including the energy industry. The dramatic decline in environmental well-being that...
NewHydrogen’s breakthrough single-atom catalyst shows better performance than platinum in lab studies
April 20, 2022 03:30 ET
|
NewHydrogen, Inc.
Company’s low-cost high-performance single-atom catalyst for alkaline hydrogen electrolyzers demonstrated higher catalytic ability and better stability compared to commercial platinum-based catalysts ...
ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting
April 18, 2022 07:30 ET
|
ContraFect Corporation
YONKERS, N.Y., April 18, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
ContraFect Announces BARDA Contract Award for Up to $86.8 Million and Provides Business Outlook
March 11, 2021 16:05 ET
|
ContraFect Corporation
BARDA to provide funding for the ongoing Phase 3 DISRUPT study of exebacase for the treatment of patients with Staph aureus bloodstream infections Results from the Phase 3 DISRUPT study interim...
Kraig Biocraft Laboratories Announces Spider Silk Patent Granted in Canada
March 02, 2021 07:05 ET
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., March 02, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), the biotechnology company focused on the development and...
Kraig Biocraft Laboratories receives its first-ever Spider Silk shipment from its Vietnamese production facility
February 23, 2021 07:05 ET
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and...
Kraig Biocraft Laboratories files for International Patents in Key Spider Silk Knock-in Knock-out Technology
February 16, 2021 07:05 ET
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and...
ContraFect Announces Appointment of Dr. Jane F. Barlow to Board of Directors
February 11, 2021 07:00 ET
|
ContraFect Corporation
YONKERS, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs)...